Overall, HB-EGF levels in plasma were significantly higher in COVID-19 total patients and COVID-19 severe group compared to the control group (p = 0.0306 and p = 0.0049, respectively) (Figure 1). The gene discussed is HBEGF; the disease is COVID-19.